NEXT Dallas

Dr. Shiraj Sen is a medical oncologist and director of NEXT Oncology Dallas. Meeting some of the first individuals with cancer treated on modern immunotherapy clinical trials and watching them feel better and live longer after being told that there were no further standard treatments for them to receive motivated him to pursue a career in drug development in order to continue bringing the newest treatments to individuals with cancer. As a native Texan, Dr. Sen calls NEXT Oncology a perfect fit for him both personally and professionally as it allows him to serve his community and provide compassionate care while developing new treatments against cancer and offering them to his patients if standard treatments are no longer helping.

BACKGROUND

Dr. Sen received his undergraduate degree from the University of Texas at Austin and his MD and PhD degrees from the University of Texas at Houston and MD Anderson Cancer Center Graduate School of Biomedical Sciences. His post graduate training in internal medicine was performed at the University of Texas Southwestern Medical Center in Dallas prior to completing his hematology and medical oncology fellowship at the University of Texas MD Anderson Cancer Center.

Dr. Sen is Board Certified in Internal Medicine and Medical Oncology and is the recipient of numerous awards for his research such as the Waun Ki Hong Award for Achievement in Clinical Investigation, the Marion D. Edwards Fellowship in Hepatic Oncology, and the American Society of Clinical Oncology (ASCO) Conquer Cancer Foundation merit award. He has also authored more than 30 peer-reviewed publications, presented his research at over 20 international conferences, and has served as a member of the ASCO Scientific Program Committee.

Dr. Michael Song is a medical oncologist and hematologist, as well as a board certified internal medicine physician. He has over 22 years of experience in cancer patient care and cancer research. He is a compassionate physician who recognizes the critical importance of physician-patient partnership in cancer care. He also recognizes the value of patient and family empowerment through knowledge sharing on cancer and cancer treatments. His interest in cancer care is in bringing new treatment options to cancer patients through Phase 1 clinical trials.

BACKGROUND:

Dr. Song completed his fellowship training in Hematology & Medical Oncology at Baylor College of Medicine in Houston, Texas. Prior to fellowship, he completed his residency training in Internal Medicine at The University of Texas Health Science Center at San Antonio. He is a graduate of the combined MD/PhD program at Texas Tech University Health Sciences Center in Lubbock, Texas. His PhD was in biochemistry, cellular & molecular biology, with research work focused on cancer molecular biology. His prior research work includes studies in molecular mechanisms of cancer treatment resistance, cancer cell and xenograft model establishment and characterization, and translational and clinical research. Prior to his MD/PhD training, Dr. Song obtained PharmD from the University of Texas at Austin College of Pharmacy and worked for nearly 8 years as an oncology clinical staff pharmacist at Parkland Hospital in Dallas, Texas. He is a graduate of Clear Lake High School in Houston, Texas and obtained his Bachelor’s degree from the University of Texas at Austin.